A detailed history of Loomis Sayles & CO L P transactions in Merck & Co., Inc. stock. As of the latest transaction made, Loomis Sayles & CO L P holds 131,424 shares of MRK stock, worth $12.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
131,424
Previous 74,929 75.4%
Holding current value
$12.9 Million
Previous $9.28 Million 60.89%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $6.28 Million - $7.29 Million
56,495 Added 75.4%
131,424 $14.9 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $4.68 Million - $5.02 Million
37,763 Added 101.61%
74,929 $9.28 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $544,231 - $634,151
-4,806 Reduced 11.45%
37,166 $4.9 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $3.32 Million - $3.61 Million
33,110 Added 373.62%
41,972 $4.58 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $266,331 - $295,771
-2,587 Reduced 22.6%
8,862 $913,000
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $3.8 Million - $4.14 Million
-35,000 Reduced 75.35%
11,449 $1.32 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $349,378 - $389,834
-3,394 Reduced 6.81%
46,449 $4.94 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $100,293 - $128,590
1,147 Added 2.36%
49,843 $5.53 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $27.5 Million - $30.9 Million
-324,995 Reduced 86.97%
48,696 $4.19 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $18.8 Million - $21.4 Million
-225,642 Reduced 37.65%
373,691 $34.1 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $13.7 Million - $15.4 Million
186,476 Added 45.17%
599,333 $49.2 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $12.6 Million - $15.8 Million
-174,861 Reduced 29.75%
412,857 $31.6 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $4.09 Million - $4.5 Million
57,083 Added 10.76%
587,718 $44.1 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $4.84 Million - $5.36 Million
-68,897 Reduced 11.49%
530,635 $41.3 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $31.6 Million - $37.2 Million
459,227 Added 327.31%
599,532 $46.2 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $9.11 Million - $10.1 Million
126,911 Added 947.52%
140,305 $11.5 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $75,082 - $85,106
-1,026 Reduced 7.12%
13,394 $1.11 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $392 Million - $446 Million
-5,572,043 Reduced 99.74%
14,420 $1.12 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $19.3 Million - $26.7 Million
-304,307 Reduced 5.17%
5,586,463 $430 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $15.8 Million - $17.8 Million
203,474 Added 3.58%
5,890,770 $536 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $3.87 Million - $4.22 Million
50,863 Added 0.9%
5,687,296 $479 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $140,867 - $164,567
2,017 Added 0.04%
5,636,433 $473 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $2.49 Million - $2.84 Million
35,741 Added 0.64%
5,634,416 $469 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $19.8 Million - $23 Million
-303,948 Reduced 5.15%
5,598,675 $428 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $6.45 Million - $7.58 Million
-111,773 Reduced 1.86%
5,902,623 $419 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $1.43 Million - $1.68 Million
28,199 Added 0.47%
6,014,396 $365 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $643,522 - $747,956
12,628 Added 0.21%
5,986,197 $326 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $2.24 Million - $2.68 Million
43,465 Added 0.73%
5,973,569 $336 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $4.06 Million - $4.37 Million
69,251 Added 1.18%
5,930,104 $380 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,860,853
5,860,853 $376 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.